| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |